ImmuONE is a biotech company established in April 2019 and is home to experienced scientists. Dr Victoria Hutter and Dr Abigail Martin started ImmuONE because they are strong believers in the need for relevant alveolar models that better represent human physiology. Abigail commercially validated her developed model during her Ph.D. which led to further support and funding by InnovateUK.
ImmuONE continues to grow at a fast pace and pioneers to innovate in vitro technologies helping a wide range of industries to gain better safety predictions while meeting their sustainability goals.
Our mission is leading translational innovations and knowledge in the lung and immune cell systems for relevant human safety assessments and fast product to market outcomes.
Meet the people pushing boundaries in cell culture applications
We welcome strategic partnerships and collaborations with trailblazing innovators and institutes for opportunities with breakthrough concepts and technologies